Celldex Therapeutics
CLDX
#4701
Rank
A$2.96 B
Marketcap
A$44.58
Share price
-0.51%
Change (1 day)
10.33%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.90 Billion

According to Celldex Therapeutics's latest financial reports the company has A$0.90 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$1.20 B90.65%
2023-12-31$A$0.62 B31.41%
2022-12-31$A$0.47 B-17.15%
2021-12-31$A$0.57 B112.51%
2020-12-31$A$0.27 B102.74%
2019-12-31$A$0.13 B-23.74%
2018-12-31$A$0.17 B-41.84%
2017-12-31$A$0.30 B-17.78%
2016-12-31$A$0.36 B-7.53%
2015-12-31$A$0.39 B53.98%
2014-12-31$A$0.25 B-27.86%
2013-12-31$A$0.35 B289.02%
2012-12-31$A$92.16 M37.51%
2011-12-31$A$67.02 M-9.53%
2010-12-31$A$74.08 M-9.78%
2009-12-31$A$82.11 M219.48%
2008-12-31$A$25.7 M-2085.31%
2007-12-31$-A$1.3 Million-147.23%
2006-12-31$A$2.74 M-90.4%
2005-12-31$A$28.54 M-42.48%
2004-12-31$A$49.63 M32.13%
2003-12-31$A$37.56 M-32.48%
2002-12-31$A$55.63 M-37.28%
2001-12-31$A$88.7 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
A$3.86 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-A$0.43 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.88 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.56 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.91 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$32.05 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A$4.22 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA